Together, these data indicate that GDNF stimulation is associated with reduced RB activity and enhanced E2F1 and AR target gene expression in a subset of prostate carcinoma that are receptive to GDNF signaling by virtue of RET and/or GFRA1 receptor expression. Here, GDNF is linked to prostate carcinoma.